Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|May 6, 2014
α-Methylated simplified resiniferatoxin (sRTX) thiourea analogues as potent and stereospecific TRPV1 antagonistsHo Shin Kim, Mi-Kyoung Jin, Sang-Uk Kang, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2010
Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-gamma-lactones as protein kinase C ligands and antitumor agentsJi-Hye Kang, Yerim Kim, Shin-Hye Won, et al.
Journal of Medicinal Chemistry|November 9, 2019
Discovery of Nonpungent Transient Receptor Potential Vanilloid 1 (TRPV1) Agonist as Strong Topical AnalgesicJihyae Ann, Ho Shin Kim, Shivaji A Thorat, et al.
European Journal of Medicinal Chemistry|September 1, 2019
Discovery of dual-acting opioid ligand and TRPV1 antagonists as novel therapeutic agents for painHobin Lee, Songyeon Ahn, Jihyae Ann, et al.
Journal of Medicinal Chemistry|December 13, 2007
Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analoguesHyungChul Ryu, Mi-Kyoung Jin, Su Yeon Kim, et al.
Bioorganic & Medicinal Chemistry|January 13, 2009
Non-vanillyl resiniferatoxin analogues as potent and metabolically stable transient receptor potential vanilloid 1 agonistsHyun-Kyung Choi, Sun Choi, Yoonji Lee, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2013
Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligandsMyeong Seop Kim, Yooran Ki, Song Yeon Ahn, et al.
European Journal of Human Genetics : EJHG|April 21, 2005
Association of DLG5 R30Q variant with inflammatory bowel diseaseMark J Daly, Alexandra V Pearce, Lisa Farwell, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2016
Discovery of N-(3-fluoro-4-methylsulfonamidomethylphenyl)urea as a potent TRPV1 antagonistic templateJihyae Ann, Wei Sun, Xing Zhou, et al.
Pageof 8